Emerging evidence shows that RIP1, RIP3, and downstream MLKL serve as predominant regulators in necroptosis while genetic deletion or pharmalogical inhibition of these key genes significantly reduced cisplatin-induced AKI (Linkermann et al., 2013, 2014; Xu et al., 2015). Here, MLKL is linked to acute kidney injury.